CFO
OMCL icon

CVA Family Office’s Omnicell OMCL Stock Holding History

CVA Family Office’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$480 – 1330
2024
Q3 		$480 Buy
+11
New +$415 ﹤0.01% 1225

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CVA Family Office's OMCL Position: Q4 2024 in Review

CVA Family Office sold out of Omnicell (OMCL) in Q4 2024, closing a stake of 11 shares — an estimated $480 sold.

CVA Family Office first reported a position in OMCL in Q3 2024 and held it in 1 quarter. The position peaked at $480 in Q3 2024. 279 funds tracked by Wall St. Rank hold OMCL as of Q4 2024.

  • CVA Family Office reported no remaining Omnicell position as of Q4 2024 after selling out during the quarter.
  • CVA Family Office sold 11 Omnicell shares in Q4 2024, an estimated $480.
  • CVA Family Office first reported a position in Omnicell in Q3 2024 and held it in 1 quarter.
  • CVA Family Office's Omnicell position peaked at $480 in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Omnicell as of Q4 2024.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.